Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study

Xu Chen, Fang Zheng, Yanhua Qing, Shuizi Ding, Danhui Yang, Cheng Lei, Zhilan Yin, Xianglin Zhou, Dixuan Jiang, Qi Zuo, Jun He, Jianlei Lv, Ping Chen, Yan Chen, Hong Peng, Honghui Li, Yuanlin Xie, Jiyang Liu, Zhiguo Zhou, View ORCID ProfileHong Luo
doi: https://doi.org/10.1101/2020.03.03.20030353
Xu Chen
1Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China
2Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China
3Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fang Zheng
4Department of Respiratory and Critical Care Medicine, the First Hospital of Changsha City, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanhua Qing
5Department of Respiratory and Critical Care Medicine, Loudi Central Hospital, Loudi, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuizi Ding
1Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China
2Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China
3Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danhui Yang
1Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China
2Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China
3Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheng Lei
1Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China
2Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China
3Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhilan Yin
1Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China
2Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China
3Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xianglin Zhou
1Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China
2Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China
3Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, Hunan, China
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dixuan Jiang
4Department of Respiratory and Critical Care Medicine, the First Hospital of Changsha City, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qi Zuo
4Department of Respiratory and Critical Care Medicine, the First Hospital of Changsha City, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun He
4Department of Respiratory and Critical Care Medicine, the First Hospital of Changsha City, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianlei Lv
4Department of Respiratory and Critical Care Medicine, the First Hospital of Changsha City, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ping Chen
1Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China
2Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China
3Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yan Chen
1Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China
2Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China
3Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Peng
1Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China
2Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China
3Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Honghui Li
5Department of Respiratory and Critical Care Medicine, Loudi Central Hospital, Loudi, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuanlin Xie
4Department of Respiratory and Critical Care Medicine, the First Hospital of Changsha City, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiyang Liu
4Department of Respiratory and Critical Care Medicine, the First Hospital of Changsha City, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhiguo Zhou
4Department of Respiratory and Critical Care Medicine, the First Hospital of Changsha City, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Luo
1Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China
2Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China
3Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, Hunan, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hong Luo
  • For correspondence: luohonghuxi@csu.edu.cn zhouzhiguo1217@163.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The clinical outcomes of COVID-19 patients in Hubei and other areas are different. We aim to investigate the epidemiological and clinical characteristics of patient with COVID-19 in Hunan which is adjacent to Hubei.

Methods In this double-center, observational study, we recruited all consecutive patients with laboratory confirmed COVID-19 from January 23 to February 14, 2020 in two designated hospitals in Hunan province, China. Epidemiological and clinical data from patients’ electronic medical records were collected and compared between mild, moderate and severe/critical group in detail. Clinical outcomes were followed up to February 20, 2020.

Findings 291 patients with COVID-19 were categorized into mild group (10.0%), moderate group (72.8%) and severe/critical group (17.2%). The median age of all patients was 46 years (49.8% were male). 86.6% patients had an indirect exposure history. The proportion of patients that had been to Wuhan in severe/critical group (48.0% vs 17.2%, p=0.006) and moderate group (43.4% vs 17.2%, p=0.007) were higher than mild group. Fever (68.7%), cough (60.5%), and fatigue (31.6%) were common symptoms especially for severe and critical patients. Typical lung imaging finding were bilateral and unilateral ground glass opacity or consolidation. Leukopenia, lymphopenia and eosinopenia occurred in 36.1%, 22.7% and 50.2% patients respectively. Increased fibrinogen was detected in 45 of 58 (77.6%) patients with available results. 29 of 44 (65.9%) or 22 of 40 (55.0%) patients were positive in Mycoplasma pneumonia or Chlamydia pneumonia antibody test respectively. Compared with mild or moderate group, severe/critical group had a relative higher level of neutrophil, Neutrophil-to-Lymphocyte Ratio, h-CRP, ESR, CK, CK–MB, LDH, D-dimer, and a lower level of lymphocyte, eosinophils, platelet, HDL and sodium (all p<0.01). Most patients received antiviral therapy and Chinese Medicine therapy. As of February 20, 2020, 159 (54.6%) patients were discharged and 2 (0.7%) patients died during hospitalization. The median length of hospital stay in discharged patients was 12 days (IQR: 10-15).

Interpretation The epidemiological and clinical characteristics of COVID-19 patients in Hunan is different from patients in Wuhan. The proportion of patients that had been to Wuhan in severe/critical group and moderate group were higher than mild group. Laboratory and imaging examination can assist in the diagnosis and classification of COVID-19 patients.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by the National Natural Science Foundation of China (81770002 to Hong Luo), Coronavirus disease 2019 Prevention and Control Emergency Project in Hunan Province (2020SK3013 to Yuanlin Xie, 2020SK3014 to Jiyang Liu), the Science and Technology Program of Changsha, China (kq1901120 to Hong Luo) and the National Key Clinical Specialty Construction Projects of China.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 06, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study
Xu Chen, Fang Zheng, Yanhua Qing, Shuizi Ding, Danhui Yang, Cheng Lei, Zhilan Yin, Xianglin Zhou, Dixuan Jiang, Qi Zuo, Jun He, Jianlei Lv, Ping Chen, Yan Chen, Hong Peng, Honghui Li, Yuanlin Xie, Jiyang Liu, Zhiguo Zhou, Hong Luo
medRxiv 2020.03.03.20030353; doi: https://doi.org/10.1101/2020.03.03.20030353
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study
Xu Chen, Fang Zheng, Yanhua Qing, Shuizi Ding, Danhui Yang, Cheng Lei, Zhilan Yin, Xianglin Zhou, Dixuan Jiang, Qi Zuo, Jun He, Jianlei Lv, Ping Chen, Yan Chen, Hong Peng, Honghui Li, Yuanlin Xie, Jiyang Liu, Zhiguo Zhou, Hong Luo
medRxiv 2020.03.03.20030353; doi: https://doi.org/10.1101/2020.03.03.20030353

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Respiratory Medicine
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10779)
  • Forensic Medicine (8)
  • Gastroenterology (583)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (864)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)